Herein, we used dCas9 fused to the TET1 catalytic domain (TET1CD) and co-treated with various combinations of sgRNA to demonstrate targeted epigenetic editing namely demethylation at the promoter of BRCA1, a model tumour suppressor gene. Here, BRCA1 is linked to neoplasm.